ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Site-targeted proximal complement C3 inhibition, but not C5 blockade, attenuates neurodegeneration in a mouse model of amyotrophic lateral sclerosis: Implications for failed clinical trials.
Moumita Majumder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.